Nearly 25% of eligible Americans now screened for lung cancer

About 24.4% of eligible Americans are screened for lung cancer via low-dose CT imaging, according to new data from the American Lung Association released Monday. 

The number represents a marked gain from the 18.2% screening rate seen in 2022, but is still well short of expectations, the ALA says. Screening rates also vary widely by state, with Massachusetts reporting the highest mark at 38.7%, while South Dakota fell last, at 13.5%. 

Over 229,000 individuals will be diagnosed with lung cancer in the U.S. this year, with the disease remaining America’s No. 1 cancer killer. The national rate of five-year lung cancer incidence was 52.1 per 100,000 individuals, with Utah reporting the lowest case rate (24.6) and Kentucky the highest (83.9). 

Since the ALA began issuing these reports nine years ago, the five-year survival rate has leapt from 18.1% to 31%, amid gains in LDCT delivery. 

“Unfortunately, not all communities have benefitted from this progress,” Harold Wimmer, president and CEO of the American Lung Association, said in a statement Nov. 16. “Awareness is still low and challenges remain. We must continue to drive progress on lung cancer screening, comprehensive biomarker testing, clinical trials and effective treatments to help people live longer, fuller lives after a lung cancer diagnosis.”

Subscribe to Radiology Business News

Lung cancer has one of the lowest five-year survival rates because cases often are diagnosed at later stages, when the disease has spread and treatment options are less effective. The national average of people alive five years after diagnosis is about 31%, with Massachusetts logging the highest rate (40.9%) and Alabama the lowest (23.8%). Meanwhile, only about 29.3% of cases are diagnosed at an early stage. Rhode Island has the highest figure at 38%, while Hawaii has the lowest (21.9%). 

Lung cancer screening with low-dose CT has been recommended for those at high risk since 2013, the report notes. ALA hopes this data and ongoing advocacy can help further push these numbers upward in its fight against the deadly disease. The association also highlighted racial disparities in lung cancer diagnosis, with black individuals 13% less likely to be diagnosed early and Latinos about 18% less likely. 

“Lung cancer screening for those at high risk gives us hope in the effort to defeat lung cancer and represents an opportunity to save more lives,” the report notes. “For screening to have the most impact on national and statewide lung cancer mortality rates, more of the high-risk population should be screened annually,” it added. 

Radiology Business Marty Stempniak

Marty Stempniak has covered healthcare since 2012, with his byline appearing in the American Hospital Association's member magazine, Modern Healthcare and McKnight's. Prior to that, he wrote about village government and local business for his hometown newspaper in Oak Park, Illinois. He won a Peter Lisagor and Gold EXCEL awards in 2017 for his coverage of the opioid epidemic. 

Subscribe to Radiology Business News

Subscribe to Radiology Business News